Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18200525rdf:typepubmed:Citationlld:pubmed
pubmed-article:18200525lifeskim:mentionsumls-concept:C1510411lld:lifeskim
pubmed-article:18200525lifeskim:mentionsumls-concept:C0014806lld:lifeskim
pubmed-article:18200525lifeskim:mentionsumls-concept:C1704353lld:lifeskim
pubmed-article:18200525lifeskim:mentionsumls-concept:C0011682lld:lifeskim
pubmed-article:18200525lifeskim:mentionsumls-concept:C0205390lld:lifeskim
pubmed-article:18200525lifeskim:mentionsumls-concept:C0004916lld:lifeskim
pubmed-article:18200525pubmed:issue9lld:pubmed
pubmed-article:18200525pubmed:dateCreated2008-8-5lld:pubmed
pubmed-article:18200525pubmed:abstractTextAn in-line near infrared (NIR) spectrometer was employed to monitor phase transformations of erythromycin dihydrate during a miniaturized fluid bed drying process. The pellets, containing 50% (w/w) erythromycin dihydrate and 50% (w/w) microcrystalline cellulose, were dried at 30, 45, and 60 degrees C. Principal component analysis was used to determine solid-state changes. For this purpose the wavelength range of 1360-2000 nm was selected and preprocessed to remove multiplicative effects. Transformation to erythromycin dehydrate was observed for the pellets dried at 45 and 60 degrees C by NIR spectrometry and X-ray powder diffractometry (XRPD). The formation of erythromycin dehydrate was observed at a moisture content 1.4% (w/w) (mass of water per dry mass of sample) while at 1.8% (w/w) neither XRPD nor NIR were able to detect dehydration. Transformation to erythromycin dehydrate therefore depends strongly on the moisture content of the pellets.lld:pubmed
pubmed-article:18200525pubmed:languageenglld:pubmed
pubmed-article:18200525pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18200525pubmed:citationSubsetIMlld:pubmed
pubmed-article:18200525pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18200525pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18200525pubmed:statusMEDLINElld:pubmed
pubmed-article:18200525pubmed:monthSeplld:pubmed
pubmed-article:18200525pubmed:issn1520-6017lld:pubmed
pubmed-article:18200525pubmed:authorpubmed-author:HeinämäkiJyrk...lld:pubmed
pubmed-article:18200525pubmed:authorpubmed-author:YliruusiJouko...lld:pubmed
pubmed-article:18200525pubmed:authorpubmed-author:RantanenJukka...lld:pubmed
pubmed-article:18200525pubmed:authorpubmed-author:MiroshnykInna...lld:pubmed
pubmed-article:18200525pubmed:authorpubmed-author:SandlerNiklas...lld:pubmed
pubmed-article:18200525pubmed:authorpubmed-author:RömerMeikeMlld:pubmed
pubmed-article:18200525pubmed:authorpubmed-author:KivikeroNiina...lld:pubmed
pubmed-article:18200525pubmed:issnTypeElectroniclld:pubmed
pubmed-article:18200525pubmed:volume97lld:pubmed
pubmed-article:18200525pubmed:ownerNLMlld:pubmed
pubmed-article:18200525pubmed:authorsCompleteYlld:pubmed
pubmed-article:18200525pubmed:pagination4020-9lld:pubmed
pubmed-article:18200525pubmed:meshHeadingpubmed-meshheading:18200525...lld:pubmed
pubmed-article:18200525pubmed:meshHeadingpubmed-meshheading:18200525...lld:pubmed
pubmed-article:18200525pubmed:meshHeadingpubmed-meshheading:18200525...lld:pubmed
pubmed-article:18200525pubmed:meshHeadingpubmed-meshheading:18200525...lld:pubmed
pubmed-article:18200525pubmed:meshHeadingpubmed-meshheading:18200525...lld:pubmed
pubmed-article:18200525pubmed:year2008lld:pubmed
pubmed-article:18200525pubmed:articleTitlePhase transformation of erythromycin A dihydrate during fluid bed drying.lld:pubmed
pubmed-article:18200525pubmed:affiliationDivision of Pharmaceutical Technology, Faculty of Pharmacy, University of Helsinki, PO Box 56, 00014 Helsinki, Finland. meike.romer@helsinki.filld:pubmed
pubmed-article:18200525pubmed:publicationTypeJournal Articlelld:pubmed